Credit Suisse Ag Intercept Pharmaceuticals, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$9.99 - $18.71 $897,381 - $1.68 Million	-89,828 Reduced 56.23%	69,928 $1.3 Million
Q2 2023 Aug 11, 2023	BUY	$9.17 - $19.29 $300,711 - $632,576	32,793 Added 25.83%	159,756 $1.77 Million
Q1 2023 May 10, 2023	SELL	$12.53 - $21.71 $241,164 - $417,852	-19,247 Reduced 13.16%	126,963 $1.71 Million
Q4 2022 Feb 13, 2023	BUY	$11.61 - $16.11 $510,062 - $707,760	43,933 Added 42.95%	146,210 $1.81 Million
Q3 2022 Nov 10, 2022	SELL	$12.21 - $19.7 $4,358 - $7,032	-357 Reduced 0.35%	102,277 $1.43 Million

Q2 2022 Aug 12, 2022	SELL	$11.23 - $19.59 $12,420 - $21,666	-1,106 Reduced 1.07%	102,634 $1.42 Million
Q1 2022 May 16, 2022	BUY	$13.37 - $17.79 $101,291 - $134,777	7,576 Added 7.88%	103,740 $1.69 Million
Q4 2021 Feb 14, 2022	BUY	$14.28 - $19.53 $459,987 - $629,100	32,212 Added 50.37%	96,164 $1.57 Million
Q3 2021 Nov 12, 2021	SELL	$12.99 - $20.47 $9,521 - $15,004	-733 Reduced 1.13%	63,952 $950,000
Q2 2021 Aug 16, 2021	SELL	$15.46 - $24.5 $308,983 - $489,657	-19,986 Reduced 23.6%	64,685 $1.29 Million
Q1 2021 May 14, 2021	SELL	$19.33 - $37.75 $907,388 - $1.77 Million	-46,942 Reduced 35.67%	84,671 $1.95 Million
Q4 2020 Feb 12, 2021	SELL	$24.48 - $42.47 $155,496 - $269,769	-6,352 Reduced 4.6%	131,613 $3.25 Million
Q3 2020 Nov 13, 2020	BUY	$39.09 - $53.44 $383,707 - $524,567	9,816 Added 7.66%	137,965 $5.72 Million
Q2 2020 Aug 12, 2020	SELL	$46.7 - $92.04 $3.37 Million - $6.65 Million	-72,201 Reduced 36.04%	128,149 $6.14 Million
Q1 2020 May 13, 2020	BUY	$48.35 - $118.68 $3.24 Million - $7.96 Million	67,035 Added 50.28%	200,350 $12.6 Million
Q4 2019 Feb 12, 2020	SELL	$57.36 - $124.1 $1.33 Million - $2.87 Million	-23,144 Reduced 14.79%	133,315 $16.5 Million
Q3 2019 Nov 12, 2019	SELL	$58.69 - $80.46 $2.82 Million - $3.86 Million	-47,969 Reduced 23.46%	156,459 $10.4 Million
Q2 2019 Aug 14, 2019	BUY	$77.77 - $120.68 $7.29 Million - $11.3 Million	93,726 Added 84.67%	204,428 $16.3 Million
Q1 2019 May 14, 2019	SELL	$91.83 - $120.68 $578,345 - $760,042	-6,298 Reduced 5.38%	110,702 $12.4 Million
Q4 2018 Feb 13, 2019	BUY	$85.79 - $126.46 $1.18 Million - $1.75 Million	13,799 Added 13.37%	117,000 $11.8 Million
Q3 2018 Nov 13, 2018	SELL	$88.49 - $127.55 $1.71 Million - $2.47 Million	-19,360 Reduced 15.8%	103,201 $13 Million
Q2 2018 Aug 14, 2018	SELL	$60.0 - $85.67 $2.43 Million - $3.47 Million	-40,470 Reduced 24.82%	122,561 $10.3 Million
Q1 2018 May 15, 2018	BUY	$52.72 - $67.25 $388,757 - $495,901	7,374 Added 4.74%	163,031 $10 Million
Q4 2017 Feb 14, 2018	SELL	$58.2 - $72.76 $2.13 Million - $2.66 Million	-36,526 Reduced 19.01%	155,657 $9.09 Million
Q3 2017 Nov 14, 2017	BUY	$57.01 - $118.75 $2.54 Million - $5.29 Million	44,578 Added 30.2%	192,183 $11.2 Million
Q2 2017 Aug 14, 2017	BUY	N/A	147,605	147,605 $17.9 Million

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account